NTZ for cryptosporidiosis: larger expanded access; buyers' club/FDA conflict. Food and Drug Administration.
Cooper
S
S
D000533:Altruism; D002986:Clinical Trials as Topic; D003255:Consumer Organizations; D003457:Cryptosporidiosis / Q000188:drug therapy*; D004345:Drug Industry; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D009574:Nitro Compounds; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational; D009574:Nitro Compounds; D013844:Thiazoles; D014230:Triazoles; C041747:nitazoxanide